The work, as detailed in this proposal, has focused on the mechanism(s) of protection that Suppressor of Cytokine Signaling - 1 (SOCS-1) confers in the setting of hyperoxic acute lung injury (HALI). Our preliminary data demonstrated that adenoviral treated mice that overexpress the suppressor of cytokine signaling-1(Ad-SOCS-1) are remarkably resistant to hyperoxic acute lung injury (HALI) and live significantly longer in hyperoxia when compared to green fluorescent protein tagged adeno virus (Ad-GFP) treated mice. SOCS-1 overexpressing mice are protected from hyperoxia-induced inflammation, which is associated with inactivation of purinergic P2X7 receptor (P2X7R)-mediated inflammasome, thus demonstrating a critical role for SOCS-1 in inflammasome-mediated inflammation. Either inflammasome silencing or SOCS-1 overexpression in monocytic cell line (THP-1) and co-cultured with alveolar type II (ATII) monolayer abolishes hyperoxia induced transepithelial permeability across mouse ATII cell monolayers and abrogates hyperoxia-induced secretion of pro-inflammatory cytokines. SOCS-1 overexpressing mice are protected from hyperoxia-induced inflammation and apoptosis, which is associated with apoptosis signal-regulating kinase 1 (ASK-1) inhibition. SOCS-1- induced protection against oxidant-induced death-inducing signaling complex (DISC) mediated apoptosis is associated with ASK-1 ubiquitination and degradation. These studies lead us to hypothesize that SOCS-1 confers protection against HALI by inhibiting inflammasome-mediated inflammation and DISC-induced apoptosis via ASK-1 degradation. We propose the following specific aims to investigate our hypothesis:
Aim 1 : To identify the role of ASK-1 in SOCS-1-induced protection against hyperoxia-induced DISC and inflammasome formation.
Aim 2 : To determine whether activation of ASK-1 has a role in hyperoxia-induced P2X7R mediated inflammasome formation.
Aim 3 : To identify the role of inflammasome in SOCS-1-induced protection against hyperoxia-induced inflammation and epithelial permeability. The proposed studies will elucidate the mechanisms by which SOCS-1 protects against HALI and will identify the cellular processes and genes critical for protection of the lung. The proposed studies will elucidate the precise role of SOCS-1 mediated inflammasome in acute lung injury (ALI) could also lead to the discovery of a totally novel therapeutic class of drugs that suppresses inflammation in ALI.

Public Health Relevance

Hyperoxia is a necessary part of treatment for patients with cardiovascular and pulmonary diseases. However, prolonged exposure to hyperoxia leads to acute lung injury (ALI). ALI is a major clinical problem in the United States with an estimated incidence rate of 262,500 patients and 40-50% mortality. Our preliminary data suggest that SOCS-1 protects against hyperoxia-induced inflammation and apoptosis. These protective effects of SOCS-1 in the setting of oxidative injury are associated with inflammasome inactivation. In this proposal we will study the role of inflammasome in acute lung injury. Our work may uncover new disease mechanisms and therapeutic approaches for lung injury associated syndromes.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL105932-01
Application #
8021936
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Harabin, Andrea L
Project Start
2011-02-01
Project End
2016-01-31
Budget Start
2011-02-01
Budget End
2012-01-31
Support Year
1
Fiscal Year
2011
Total Cost
$367,500
Indirect Cost
Name
University of South Florida
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
069687242
City
Tampa
State
FL
Country
United States
Zip Code
33612
Soundararajan, Ramani; Stearns, Timothy M; Czachor, Alexander et al. (2016) Global gene profiling of aging lungs in Atp8b1 mutant mice. Aging (Albany NY) 8:2232-2252
Fukumoto, Jutaro; Cox Jr, Ruan; Fukumoto, Itsuko et al. (2016) Deletion of ASK1 Protects against Hyperoxia-Induced Acute Lung Injury. PLoS One 11:e0147652
Galam, Lakshmi; Soundararajan, Ramani; Breitzig, Mason et al. (2016) SOCS-1 rescues IL-1β-mediated suppression of epithelial sodium channel in mouse lung epithelial cells via ASK-1. Oncotarget 7:29081-91
Galam, Lakshmi; Rajan, Ashna; Failla, Athena et al. (2016) Deletion of P2X7 attenuates hyperoxia-induced acute lung injury via inflammasome suppression. Am J Physiol Lung Cell Mol Physiol 310:L572-81
Leung, Joseph; Cho, Young; Lockey, Richard F et al. (2015) The Role of Aging in Idiopathic Pulmonary Fibrosis. Lung 193:605-10
Soundararajan, Ramani; Stearns, Timothy M; Griswold, Anthony L et al. (2015) Detection of canonical A-to-G editing events at 3' UTRs and microRNA target sites in human lungs using next-generation sequencing. Oncotarget 6:35726-36
Rajanbabu, Venugopal; Galam, Lakshmi; Fukumoto, Jutaro et al. (2015) Genipin suppresses NLRP3 inflammasome activation through uncoupling protein-2. Cell Immunol 297:40-5
Cho, Seong H; Kim, Dae Woo; Lee, Sun H et al. (2015) Age-related increased prevalence of asthma and nasal polyps in chronic rhinosinusitis and its association with altered IL-6 trans-signaling. Am J Respir Cell Mol Biol 53:601-6
Cox Jr, Ruan; Phillips, Oluwakemi; Fukumoto, Jutaro et al. (2015) Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment. Am J Respir Cell Mol Biol 53:422-35
Saco, Tara Vinyette; Parthasarathy, Prasanna Tamarapu; Cho, Young et al. (2015) Micro RNAs: the future of idiopathic pulmonary fibrosis therapy. Cell Biochem Biophys 71:509-11

Showing the most recent 10 out of 44 publications